FDA Warning Letter — Guangxi Yulin Pharmaceutical Group Co. Ltd.
The FDA took a Warning Letter action against Guangxi Yulin Pharmaceutical Group Co. Ltd. on Sep 30, 2025 (Yulin, China). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Guangxi Yulin Pharmaceutical Group Co. Ltd.
- Date
- Sep 30, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Center
- CDER
- Location
- Yulin (China)